Floatz logo

35 assets in Gastric Neoplasm

Therapeutic assets addressing Gastric Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fluorouracilum
Gastric Neoplasm
Seagen, a wholly owned subsidiary of PfizerP4BBB (73)
Capecitabine
Gastric Neoplasm
SUNHO（China）BioPharmaceutical CO., Ltd.P3BB (70)
Oxaliplatin
Gastric Neoplasm
SUNHO（China）BioPharmaceutical CO., Ltd.P3BB (68)
Cis-Diamminedichloroplatinum Ii
Gastric Neoplasm
Jazz PharmaceuticalsP3BB (67)
Cyclophosphamide
Gastric Neoplasm
National Cancer Institute (NCI)P3BB (66)
Pembrolizumab
Gastric Neoplasm
Merck Sharp & Dohme LLCP3BB (66)
Trastuzumab
Gastric Neoplasm
SUNHO（China）BioPharmaceutical CO., Ltd.P3BB (65)
Carboplatin
Gastric Neoplasm
Merck Sharp & Dohme LLCP2B (61)
Tislelizumab
Gastric Neoplasm
Jazz PharmaceuticalsP3B (60)
Zanidatamab
Gastric Neoplasm
Jazz PharmaceuticalsP3B (60)
Docetaxel
Gastric Neoplasm
Merck Sharp & Dohme LLCP2B (57)
Lenvatinib
Gastric Neoplasm
Merck Sharp & Dohme LLCP2B (57)
Pembrolizumab/Vibostolimab Coformulation
Gastric Neoplasm
Merck Sharp & Dohme LLCP2B (57)
iah0968
Gastric Neoplasm
SUNHO（China）BioPharmaceutical CO., Ltd.P2/3CCC (55)
Disitamab Vedotin
Gastric Neoplasm
Seagen, a wholly owned subsidiary of PfizerP2CCC (53)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Gastric Neoplasm
Haihua YuanP2CCC (53)
Tucatinib
Gastric Neoplasm
Seagen, a wholly owned subsidiary of PfizerP2CCC (53)
esg401
Gastric Neoplasm
Shanghai Escugen Biotechnology Co., LtdP1/2CCC (52)
Petiveria Alliacea Preparation
Gastric Neoplasm
Hospital Universitario San IgnacioP1/2CCC (48)
Atezolizumab
Gastric Neoplasm
Cancer Research UKP1/2CC (45)
htl0039732 capsules
Gastric Neoplasm
Cancer Research UKP1/2CC (45)
Dostarlimab
Gastric Neoplasm
Elevation OncologyP1CC (43)
eo-3021
Gastric Neoplasm
Elevation OncologyP1CC (43)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Gastric Neoplasm
Elevation OncologyP1CC (43)
Lithium, Elemental
Gastric Neoplasm
Cancer Trials IrelandP1CC (43)
Fapi-46
Gastric Neoplasm
Karolinska University HospitalP1CC (41)
Fludarabine
Gastric Neoplasm
National Cancer Institute (NCI)P1CC (41)
ly4257496
Gastric Neoplasm
Eli Lilly and CompanyP1CC (41)
ly4337713
Gastric Neoplasm
Eli Lilly and CompanyP1CC (41)
pf-08046050
Gastric Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
Sgn-Alpv
Gastric Neoplasm
Seagen Inc.P1CC (41)
Sigvotatug Vedotin
Gastric Neoplasm
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
Tnhyp217 Car T Cells
Gastric Neoplasm
National Cancer Institute (NCI)P1CC (41)
ucb4594
Gastric Neoplasm
Cancer Research UKP1/2NR ()